FDA is investigating reports of hair loss, aspiration, and suicidal thoughts among people taking the medications
Authors dub the term benzodiazepine-induced neurological dysfunction to describe neurological complications
Implementation of training session increased proportion of patients with documented Abnormal Involuntary Movement Score
Protective effect suggested with female gender for schizophrenia patients with tardive dyskinesia
69.9 percent of sample reported acute physical health effects; 2.3 percent reported need for subsequent medical attention
<p>Findings show physical, mental, and cognitive symptoms one year after ICU stay for COVID-19</p>